КЛИНИКО–НЕЙРОФИЗИОЛОГИЧЕСКИЕ ОСОБЕННОСТИ НЕЙРОКОГНИТИВНЫХ РАССТРОЙСТВ У ДЕТЕЙ И ПОДРОСТКОВ С САХАРНЫМ ДИАБЕТОМ 1 ТИПА

1. Андрианова, Е.А. Качество метаболического контроля детей с СД 1 типа в 7-ми регионах Российской Федерации / Е.А. Андрианова // Высокие медицинские технологии в эндокринологии: материалы V Всероссийского конгресса эндокринологов. - Москва, 2006. - С. 64.

2. Дедов, И.И. Проблема контроля качества диабетологической помощи в России по данным на январь 2007 г. / И.И. Дедов, М.В. Шестакова // Сахарный диабет. - 2008. - №3. - С. 55-57.

3. Дедов, И.И. Российский консенсус по терапии сахарного диабета у детей и подростков / И.И. Дедов, В.А. Петеркова, Т.Л. Кураева // Фарматека. -2010. -№3.- С 7-14

4. Евтушенко С. К., Морозова Т. М., Шестова Е. П., Трибрат А. А., Морозова А. В. Нарушение когнитивных функций у детей: нейрофизиологическая оценка и коррекция // Международный неврологический журнал. 2010. № 1 (31). С. 64–7

5. Емелин А. Ю., Одинак М. М., Лобзин В. Ю., Воробьев С. В., Киселев В. Н. Современные возможности нейровизуализации в дифференциальной диагностике когнитивных нарушений // Неврология, нейропсихиатрия, психосоматика. 2012. Т. 4, № 2 S. C. 51–55

35. Wagner J, Heapy A, James A, Abbott G. Brief report: glycemic control, quality of life, and school experiences among students with diabetes. J Pediatr Psychol 2006; 31: 764-769 [PMID: 16162839 DOI: 10.1093/jpepsy/jsj082]

6. Петеркова, В.А. Сахарный диабет у детей и подростков: к 90-летию введения в клиническую практику инсулина / В.А. Петеркова // Фарматека.-2012.-№3.-С. 1-11

7. Петеркова, В.А. Современная инсулинотерапия сахарного диабета 1 типа у детей и подростков / В.А. Петеркова, Т.Д. Кураева // Consiliummedicum. - 2007. - Т.9. - №9. - С. 29- 33.

8. Сунцов, Ю.И. Скрининг осложнений сахарного диабета как метод оценки лечебнопрофилактической помощи больным / Ю.И. Сунцов, О.В. Маслова, И.И. Дедов // Проблемы эндокринологии. - 2010. - №1. - С. 3-

9. Austin E.J., Deary I.J. Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the diabetes control and complications trial data. Diabetes Care. 1999. № 22. Р. 1273-1277.

10. Brands A. M. A., Biessels G. J., de Haan E. H. F., Kappelle L. J., Kessels R. P. C. The effects of type 1 diabetes on cognitive performance // Diabetes Care. 2005. V. 28, № 3. P. 726–735.

11. Cognition and Type 1 Diabetes in Children and Adolescents. Allison Cato et al., Diabetes Spectr, 2016

12. Cognitive Function Following Diabetic Ketoacidosis in Children With New-Onset or Previously Diagnosed Type 1 Diabetes Simona Ghetti et al., Diabetes Care, 2020).

13. Colver A, Longwell S. New understanding of adolescent brain development: relevance to transitional healthcare for young people with long term conditions. Arch Dis Child 2013; 98: 902-907 [PMID: 23986559 DOI: 10.1136/archdischild-2013-303945]

14. De Jong RN. The nervous system complications in diabetes mellitus with special reference to cerebrovascular changes. J NervMent Dis. 1950;111:181-206

15. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: Report of a WHO/IDF consultation / World Health Organization (no authors listed) // WHO; IDF. - 2006. - 50 pp

16. Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline / Bramlage P, Binz C, Gitt AK, Krekler M, Plate T, Deeg E, Tschupe D. // Cardiovasc. Diabetol. -)

17. Gan, M.J., Albanese-O'Neill, A., Haller, M.J. Type 1 diabetes: current concepts in epidemiology, pathophysiology, clinical care, and research // Curr. Probl. Pediatr. Adolesc. Health Care. - 2012. - Vol. 42 (10). - P. 269-291.

18. Good glycemic control remains crucial in prevention of late diabetic complications—the Linkuping Diabetes Complications Study / Nordwall M., Arnqvist H.J., Bojestig M., Ludvigsson J. // Pediatr. Diabetes. - 2009. - Vol. 10 (3). -P. 168-176

19. Ho M.S., Weller N.J., Ives F.J. et al. Prevalence of structural central nervous system abnormalities in early-onset type 1 diabetes mellitus. J Pediatr. 2008. № 153. Р. 385-390.

20. Holmes CS. Disease and demographic risk factors for disrupted cognitive functioning in children with insulin - dependent diabetes mellitus (IDDM). School Psychology Review 1999; 28: 215

21. Kooistra M, Geerlings MI, Mali WP, et al. Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study. J Neurol Sci. 2013 Sep 15;332(1-2):69-74. doi: 10.1016/j.jns.2013.06.019. Epub 2013 Jul 6.

22. McCrimmon R. J., Ryan Ch. M., Frie B. M. Diabetes and cognitive dysfunction. // Available at:http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60360-2/fulltext Published online June 9, 2012.

23. Miles WR, Root HF. Psychologic tests applies in diabetic patients. Arch Intern Med (Chic). 1922;30(6):767-777. doi:10.1001/arch-inte.1922.00110120086003

24. Musen G., Lyoo I.K., Sparks C.R. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes. 2006. № 55. Р. 326-333.

25. Northam E.A., Anderson P.J., Jacobs R. et al. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care. 2001. № 24. Р. 1541-1546.

26. Northam E.A., Rankins D., Lin A. et al. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care. 2009. № 32. Р. 445-450.

27. Northam EA, Anderson PJ, Jacobs R, Hughes M, Warne GL, Werther GA. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 2001; 24: 1541-1546 [PMID: 11522696 DOI: 10.2337/diacare.24.9.1541]

28. Northam EA, Anderson PJ, Werther GA, Warne GL, Adler RG, Andrewes D. Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 1998; 21: 379-384 [PMID: 9540019 DOI: 10.2337/diacare.21.3.379]

29. Palladino DK, Helgeson VS, Reynolds KA, Becker DJ, Siminerio LM, Escobar O. Emerging adults with type 1 diabetes: a comparison to peers without diabetes. J Pediatr Psychol 2013; 38: 506-517 [PMID: 23475831 DOI: 10.1093/jpepsy/jst002]

30. Perfect MM, Jaramillo E. Relations between resiliency, diabetesrelated quality of life, and disease markers to school-related outcomes in adolescents with diabetes. Sch Psychol Q 2012; 27: 29-40 [PMID: 22582934 DOI: 10.1037/a0027984]

31. Perfect MM. The Relations of Sleep and Quality of Life to School Performance in Youth With Type 1 Diabetes. J Appl Sch Psychol 2014; 30: 7-28 [DOI: 10.1080/15377903.2013.853718]

32. Preventing macrovascular complications of diabetes: where do we stand with glycemic control? / Athyros V.G., Tziomalos K., Karagiannis A., Mikhailidis D.P. // Expert Opin. Investig. Drugs. - 2008. - Vol. 17 (12). - P. 1777 - 1779.

33. Ryan C.M. Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. Pediatr Diabetes. 2006. № 7. Р. 289-297.

34. The Diabetes Control Complications Trial / Epidemiology of Diabetes Interventions, Complications (DCCT/EDIC) Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med. 2007. № 356. Р. 1842-1852